Carbapenems in serious infections : A risk-benefit assessmentNORRBY, S. R.Drug safety. 2000, Vol 22, Num 3, pp 191-194, issn 0114-5916Article

Effect of cilastatin on cyclosporine-induced acute nephrotoxicity in kidney transplant recipientsCARMELLINI, M; FROSINI, F; FILIPPONI, F et al.Transplantation. 1997, Vol 64, Num 1, pp 164-166, issn 0041-1337Article

Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coliSCHAUMANN, Reiner; BLATZ, Rosemarie; BEER, Joerg et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 2, pp 318-324, issn 0305-7453, 7 p.Article

Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergyPRESCOTT, William A; DEPESTEL, Daryl D; ELLIS, Jeffrey J et al.Clinical infectious diseases. 2004, Vol 38, Num 8, pp 1102-1107, issn 1058-4838, 6 p.Article

Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatinMARAVI-POMA, Enrique; GENER, Joan; ALVAREZ-LERMA, Francisco et al.Intensive care medicine (Print). 2003, Vol 29, Num 11, pp 1974-1980, issn 0342-4642, 7 p.Article

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumoniaWOOD, G. Christopher; HANES, Scott D; CROCE, Martin A et al.Clinical infectious diseases. 2002, Vol 34, Num 11, pp 1425-1430, issn 1058-4838Article

Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactamJELLISON, Tara K; MCKINNON, Peggy S; RYBAK, Michael J et al.Pharmacotherapy. 2001, Vol 21, Num 2, pp 142-148, issn 0277-0008Article

Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unitVERWAEST, C.Clinical microbiology and infection. 2000, Vol 6, Num 6, pp 294-302, issn 1198-743XArticle

Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections : A canadian hospital perspectiveMARRA, F. O; FRIGHETTO, L. O; MARRA, C. A et al.The Annals of pharmacotherapy. 1999, Vol 33, Num 2, pp 156-162, issn 1060-0280Article

Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infectionsZANETTI, G; HARBARTH, S. J; GLAUSER, M et al.International journal of antimicrobial agents. 1999, Vol 11, Num 2, pp 107-113, issn 0924-8579Article

Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomesYOUSIF, T; POOYEH, S; HANNEMANN, J et al.International journal of clinical pharmacology and therapeutics. 1999, Vol 37, Num 10, pp 475-486, issn 0946-1965Article

Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis : comparison with imipenem/cilastatin in an open, randomized trialGEDDES, A; THALER, M; SCHONWALD, S et al.Journal of antimicrobial chemotherapy (Print). 1999, Vol 44, Num 6, pp 799-810, issn 0305-7453Article

Assessment of an Alternative Meropenem Dosing Strategy Compared with Imipenem-Cilastatin or Traditional Meropenem Dosing After Cefepime Failure or Intolerance in Adults with Neutropenic FeverARNOLD, Heather M; MCKINNON, Peggy S; AUGUSTIN, Kristan M et al.Pharmacotherapy. 2009, Vol 29, Num 8, pp 914-923, issn 0277-0008, 10 p.Article

Cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to β-lactamsSCHIAVINO, D; NUCERA, E; LOMBARDO, C et al.Allergy (Copenhagen). 2009, Vol 64, Num 11, pp 1644-1648, issn 0105-4538, 5 p.Article

An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumoniaFELDMAN, Charles; WHITE, Hayden; O'GRADY, John et al.International journal of antimicrobial agents. 2001, Vol 17, Num 3, pp 177-188, issn 0924-8579Article

Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transportersTAKEDA, Michio; NARIKAWA, Shinichi; HOSOYAMADA, Makoto et al.European journal of pharmacology. 2001, Vol 419, Num 2-3, pp 113-120, issn 0014-2999Article

Cost-effectiveness of ceftazidime or imipenem/cilastatin versus ceftriaxone + aminoglycoside in the treatment of febrile episodes in neutropenic cancer patients in GermanyDIETRICH, E. S; PATZ, E; FRANK, U et al.Infection. 1999, Vol 27, Num 1, pp 23-27, issn 0300-8126Article

Local treatment of generalised peritonitis in rats; Effects on bacteria, endotoxin and mortalityROSMAN, C; WESTERVELD, G. J; KOOI, K et al.The European journal of surgery. 1999, Vol 165, Num 11, pp 1072-1079, issn 1102-4151Article

Treatment of obstetric and gynecologic infections with meropenem : Comparison with imipenem/cilastatinMAGGIONI, P; DI STEFANO, F; FACCHINI, V et al.Journal of chemotherapy. 1998, Vol 10, Num 2, pp 114-121, issn 1120-009XConference Paper

Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureusNAGANO, R; SHIBATA, K; NAITO, T et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 10, pp 2278-2281, issn 0066-4804Article

Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections : Results of a prospective, randomized, multicentre trialBASOLI, A; MELI, E. Z; MAZZOCCHI, P et al.Scandinavian journal of infectious diseases. 1997, Vol 29, Num 5, pp 503-508, issn 0036-5548Article

Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipientsLASZLO, D; BACCI, S; BOSI, A et al.Journal of chemotherapy. 1997, Vol 9, Num 2, pp 95-101, issn 1120-009XConference Paper

The role of antibiotic prophylaxis in severe acute pancreatitis. DiscussionHO, H. S; FREY, C. F; PRINZ, R. A et al.Archives of surgery (Chicago, IL. 1960). 1997, Vol 132, Num 5, pp 487-493, issn 0004-0010Conference Paper

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired PneumoniaRAMIREZ, Julio; DARTOIS, Nathalie; GANDJINI, Hassan et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 4, pp 1756-1762, issn 0066-4804, 7 p.Article

Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospitalSALTOGLU, N; DALKIRAN, A; TETIKER, T et al.Clinical microbiology and infection. 2010, Vol 16, Num 8, pp 1252-1257, issn 1198-743X, 6 p.Article